http://orcid.org/0000-0002-3144-4822
Figures
Abstract
Connexin 43 (Cx43) may be important in cell death and survival due to cell-to-cell communication-independent mechanisms. In our previous study, we found that small G protein signaling modulator 3 (SGSM3), a partner of Cx43, contributes to myocardial infarction (MI) in rat hearts. Based on these previous results, we hypothesized that SGSM3 could also play a role in bone marrow-derived rat mesenchymal stem cells (MSCs), which differentiate into cardiomyocytes and/or cells with comparable phenotypes under low oxygen conditions. Cx43 and Cx43-related factor expression profiles were compared between normoxic and hypoxic conditions according to exposure time, and Sgsm3 gene knockdown (KD) using siRNA transfection was performed to validate the interaction between SGSM3 and Cx43 and to determine the roles of SGSM3 in rat MSCs. We identified that SGSM3 interacts with Cx43 in MSCs under different oxygen conditions and that Sgsm3 knockdown inhibits apoptosis and cardiomyocyte differentiation under hypoxic stress. SGSM3/Sgsm3 probably has an effect on MSC survival and thus therapeutic potential in diseased hearts, but SGSM3 may worsen the development of MSC-based therapeutic approaches in regenerative medicine. This study was performed to help us better understand the mechanisms involved in the therapeutic efficacy of MSCs, as well as provide data that could be used pharmacologically.
Citation: Jung SE, Choi J-W, Moon H, Oh S, Lim S, Lee S, et al. (2020) Small G protein signaling modulator 3 (SGSM3) knockdown attenuates apoptosis and cardiogenic differentiation in rat mesenchymal stem cells exposed to hypoxia. PLoS ONE 15(4): e0231272. https://doi.org/10.1371/journal.pone.0231272
Editor: Gianpaolo Papaccio, Università degli Studi della Campania, ITALY
Received: February 4, 2020; Accepted: March 19, 2020; Published: April 9, 2020
Copyright: © 2020 Jung et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and/or Supporting Information files.
Funding: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1D1A1B07049416) to JWC, the NRF grant funded by the Korean government (MSIT) (NRF-2018R1A2B6008629) to SWK and Korea Science and Engineering Foundation grants funded by the Korean government (MEST) (NRF-2015M3A9E6029519) to KCH.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Mesenchymal stem cells (MSCs) can isolated various sources including bone marrow, trabecular and cortical bone, adipose tissue, skeletal muscle, peripheral blood, umbilical cord blood, and dental pulp and differentiate into multi-lineage according to sources such as osteoblast, chondrocytes, adipocytes, cardiomyocytes, tenocytes, muscle cells, fibroblast, and neuron [1–5]. Over the past decades, there has been tremendous focus on attempts to repair cardiac tissue with stem cell transplantation, and MSCs have been widely studied in both animal models and clinical trials [6,7]. MSCs are considered a promising tool with clinical implications for cell-based applications for cardiac therapeutics of myocardial infarction, peripheral ischemic vascular disease, pulmonary hypertension, and dilated cardiomyopathy [4]. Recently, signaling pathway related to some regulators containing HGF, PDGF, Wnt, and Notch-1, was found that involved in proliferation and differentiation into cardiomyocytes of MSCs [5]. In ischemic heart diseases, transplanted stem cells experience sudden oxygen deficiency when transplanted into ischemic heart tissue. Stem cells adapt themselves under hypoxic microenvironments by regulating their proliferation, differentiation, metabolic balance and other physiological processes [8,9]. The oxygen microenvironment of stem cells plays an important role in controlling stem cell properties and the ability to differentiate into different mesoderm lineages [8,9]. MSCs have practical potential for differentiation into osteogenic, chondrogenic, cardiomyogenic and adipogenic cells and/or cells with comparable phenotypes under hypoxic conditions [10–13]. These changes in the MSC response to low oxygen conditions could be used as a preconditioning method for effective stem cell transplantation. Some studies have shown that hypoxic preconditioning may promote cell survival following stem cell transplantation [14,15].
Connexin 43 (Cx43) forms intracellular communication channels and is related to cell death in impairment [16]. Lu G et al., has found that increased Cx43 expression enhances cell viability, cardiomyogenic differentiation and cardiac functions after transplantation of preconditioned MSCs [17]. Furthermore, decreases in Cx43 expression are reported for nearly every type of cardiac pathology and during the acute phase of ischemia in myocardial infarction (MI) [18–20]. Ischemic preconditioning inhibits respiratory disorder from reperfusion and mitochondrial Cx43 is closely related to these mechanisms by ischemic preconditioning [21–24]. However, the mechanism of Cx43 in myocardial protections still unknown.
Despite its short half-life (as little as 1–2 h), regulation of Cx43 appears to exist on both short- and long-term scales through protein phosphorylation and interactions and gene expression, respectively [18,20]. Although several binding partners of Cx43 with gap junction-dependent and gap junction-independent functions have been found, a study about the characterization of Cx43-binding proteins remains insufficient [25]. However, less is known about the mechanistic basis and function of Cx43 protein-protein interactions [25–28]. In our previous study, we found that small G protein signaling modulator 3 (SGSM3), a partner of Cx43, contributes to MI in rat hearts [29], and inhibiting the protective effects against oxidative stress with kenpaullone was shown to involve Cx43 and SGSM3 interactions in cardiomyocytes [30]. Based on these previous results, we expected that SGSM3 could also play a role in bone marrow-derived rat MSCs, which differentiate into cardiomyocytes and/or cells with comparable phenotypes under low oxygen conditions. Here, we determined the differential expression and interaction of Cx43 and SGSM3 in MSCs under different oxygen conditions and the effects of SGSM3 knockdown on apoptosis and cardiomyocyte differentiation under hypoxic stress. To the best of our knowledge, no studies have reported on the interaction between SGSM3 and Cx43 and their effects on damage induced by a low oxygen environment in stem cells. This study was performed to help us better understand the mechanisms involved in the therapeutic efficacy of MSCs, as well as provide data that could be used pharmacologically.
Materials and methods
Rat MSC culture
Second passage bone marrow-derived Sprague-Dawley (SD) rat MSCs were purchased from Cyagen (Cat. No. RASMX-01001; Santa Clara, CA, USA). The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; HyClone, Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT, USA) and 1% penicillin/streptomycin at a density of 5×104 cells/cm2 in a 100‐mm dish in a humidified atmosphere with 5% CO2 at 37°C.
Normoxic- and hypoxic-conditioned cell preparation
Rat MSCs were incubated with serum‐free media (SFM) under normoxic or hypoxic conditions for 6, 12 or 24 h. For the hypoxic conditions, cells were incubated at 37°C in 5% CO2, 5% H2 and 0.5% O2 in a chamber with an anaerobic atmosphere system (Technomart, Seoul, Korea). The cells were harvested after the 6‐, 12‐ or 24‐h incubation period and incubated with RIPA buffer (Cell Signaling Technology, Danvers, MA, USA) for immunoblot analysis and with TRIzol Reagent (Life Technologies, Frederick, MD, USA) for quantitative real-time RT-PCR (qRT-PCR) analysis.
Normoxic- and hypoxic-conditioned cell preparation
Total RNA was isolated from rat MSCs under normoxic and hypoxic conditions using TRIzol Reagent, and cDNA was synthesized using a Maxime RT PreMix kit (iNtRON Biotechnology, Seongnam, Korea). The level of each gene transcript was determined quantitatively using a StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). A SYBR Green Dye system (SYBR Premix Ex Taq (Tli RNase Plus) with a ROX reference dye (TAKARA Bio Inc., Foster City, CA, USA) was used to perform real-time RT-PCR. All values are shown as the target gene expression level (fold change; 2ΔΔCt) normalized to the Gapdh transcript level. All primers were designed using Primer3 from BLAST (Table 1).
Immunoblot analysis
Immunoblot analyses were performed as previously described [10,31]. Briefly, cell lysates were prepared with RIPA buffer containing 1% phosphatase inhibitors (Sigma‐Aldrich, St. Louis, MO, USA), 1% protease inhibitors (Sigma‐Aldrich) and 1% proteasome inhibitors (MG132; Abcam, Cambridge, UK). The proteins were separated using SDS-PAGE and transferred to polyvinylidene difluoride (PVDF; Sigma‐Aldrich) membranes. The membranes were incubated with the appropriate primary antibodies and horseradish peroxidase (HRP)‐conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The blots were developed with enhanced chemiluminescence (ECL Western Blotting Detection Kit, GE Healthcare, Buckinghamshire, UK), and the band intensities were quantified using ImageJ software (NIH).
Transient Cx43 and Sgsm3 knockdown
To knockdown (KD) Hif1a and Sgsm3, target-specific commercial AccuTarget siRNAs (BIONEER, Daejeon, Korea) (Hif1a siRNA no. 1654508: sense (5΄-3΄), CAGUUACGAUUGUGAAGUU (dTdT); antisense (5΄-3΄), AACUUCACAAUCGUAACU G (dTdT); Sgsm3 siRNA no. 1752125: sense (5΄-3΄), CUGAUACAGUCGGAGAACU (dTdT); antisense (5΄-3΄), AGUUCUCCGACUGU AUCAG (dTdT)) were designed, and a negative control (nontargeting siRNA) was used. MSCs (1 × 106 cells per dish in a 10-mm dish) were transiently transfected with siRNA (100 nM per dish) and agent (45 μl per dish) using the TransIT-X2 Dynamic Delivery System (Mirus Bio LLC, Madison, WI, USA), and gene expression levels were examined in the cells after cultured for 24 h. The level of each gene transcript was normalized to the level of the Gapdh transcript.
Cell viability assay
MSCs were seeded at a density of 1×104 cells/well in a 96-well plate before transfection. They were transiently transfected with SGSM3 siRNA (100 nM per dish) and agent (45 μl per dish) using the TransIT-X2 Dynamic Delivery System and exposed to hypoxic stress for 12 h after 24 h. The viability of MSCs was measured using Ez-Cytox Colorimetric Cell Viability Assay Kit (DOGEN, Seoul, Korea), following the manufacturer’s instructions. This assay is based on features of water-soluble tetrazolium salt.
Immunofluorescence analysis
To investigate the expression patterns of cardiogenic markers upon Sgsm3 knockdown in MSCs under normoxic and hypoxic conditions, cells were grown on cell culture slides (SPL, Pocheon-si, Korea) and then fixed with 4% formaldehyde. The cells were then washed with PBS and subjected to permeabilization in 0.25% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA). The cell slides were washed with PBS three times, blocked with 1% BSA in PBS-T for 1 h, and then incubated with a monoclonal anti-cardiac troponin T antibody (1:200 dilution) and anti-GATA antibody (1:200) (abcam) overnight at 4°C. Next, the cells were washed three times with PBS. The cell slides were then incubated with a FITC-conjugated mouse secondary antibody (1:1000 dilution) against cardiac troponin T or a rhodamine-conjugated rabbit secondary antibody (1:1000 dilution) against GATA4. DAPI (Sigma-Aldrich) was used to stain the cell nuclei. The prepared slides were observed using an LSM700 confocal laser scanning microscope (Carl Zeiss, Oberkochen, Germany). Acquisition of the images was performed using Zen black or blue software (Carl Zeiss).
Statistical analysis
All experimental results were compared using one-way analysis of variance (ANOVA) in the Statistical Package of Social Science (SPSS, version 17) program. The data are expressed as the mean ± SEM. A protected least-significant difference (LSD) test, which is a method consisting of single-step procedures in a one-way ANOVA for analyzing multiple comparisons, was used to identify significant differences between means (p<0.05).
Results
Changes in Cx43 and SGSM3 in rat MSCs under low oxygen conditions
In a previous study, we performed a coimmunoprecipitation (CoIP) assay to identify potential Cx43 partner proteins, a peptide mass fingerprinting (PMF) analysis to identify proteins interacting with Cx43 and a network analysis using GeneMANIA to validate their correlation and find additional Cx43 partner proteins. Ultimately, SGSM3, a Cx43-interacting protein, was confirmed in rat hearts [29]. Here, we carried out these three analyses in rat MSCs as preliminary experiments and showed that there was also an interaction between Cx43 and SGSM3 in MSCs. Based on these data, Cx43 and Cx43-related factor expression profiles in MSCs were first compared between normoxic and hypoxic conditions according to exposure times. Next, we investigated the gene/protein expression of Cx43, SGSM3 and tight junction protein 1 (ZO-1), and there were differences in the expression patterns of these targets between normoxic- and hypoxic-conditioned MSCs (Fig 1). Gene and/or protein levels of hypoxia-inducible factor 1-α (Hif1α) and Cx43 were significantly increased, whereas SGSM3 and ZO-1 levels were reduced by hypoxic stress; however, the hypoxia time with the most or least expression was different for gene and protein expression (Fig 1). Accordingly, we decided to harvest cells 12 h after hypoxic stress because the conditions had distinct and differential expression patterns between the normoxic and hypoxic conditions (Fig 1).
Time-dependent differential expression of gap junction factors (Cx43, ZO-1) and SGSM3 in normoxic and hypoxic conditions in rat MSCs as determined by qRT-PCR (A) and immunoblot analysis (B). All qRT-PCR values are shown as the normalized target gene expression level relative to the GAPDH transcript levels, and the data are representative of three independent experiments (A). Band intensity was measured as the area density and analyzed in ImageJ and relative intensity levels indicate protein levels normalized to the β-actin levels (B). Significant differences between the normoxia and hypoxia groups were determined via ANOVA, with p values indicated as *p<0.01 and **p<0.001. N, normoxia; H, hypoxia; NC, negative control cells; KD, knockdown cells.
Effects of Hif1a and Sgsm3 knockdown on the expression levels of gap junction targets
For experimental proof of the interaction between SGSM3 and Cx43 and to confirm the relevance of the two proteins and Hif1α, Hif1a and Sgsm3 gene knockdown (KD) using siRNA transfection was performed in rat MSCs. After 24 h of siRNA KD, MSCs were exposed to a normoxic or hypoxic environment for 12 h. Hif1a was effectively knocked down by siRNA transfection, and Hif1a KD affected the downregulation of Cx43 expression and the upregulation of ZO-1 expression under normoxic and/or hypoxic conditions (Fig 2A). However, Hif1a KD did not change the expression of SGSM3 (Fig 2A). On the other hand, Sgsm3 was substantially knocked down by siRNA transfection, and Sgsm3 KD significantly increased the expression of Hif1α and Cx43 and attenuated the expression of ZO-1 (Fig 2B). It can be inferred that SGSM3 is closely related to Cx43, Hif1α, and ZO-1
Effects of Hif1a (A) and Sgsm3 (B) knockdown on Cx43 and SGSM3 expression levels in rat MSCs under normoxic and hypoxic conditions, as measured via immunoblot analysis. Band intensity was measured as the area density and analyzed in ImageJ and relative intensity levels indicate protein levels normalized to the β-actin levels. The data are representative of two independent experiments. Significant differences between groups were determined via ANOVA, with p values indicated as *p<0.05 and **p<0.01. N, normoxia; H, hypoxia; NC, negative control cells; KD, knockdown cells.
Effects of Sgsm3 KD on cell apoptosis under hypoxic stress
To determine the effects of Sgsm3 KD on cell death induced by hypoxic stress in rat MSCs, the viability of control and Sgsm3 KD cells was investigated under normoxic and hypoxic conditions. We found that Sgsm3 KD significantly prevented cell death induced by low oxygen under both normoxic and hypoxic conditions (Fig 3A). On the basis of these results, we hypothesized that Sgsm3 KD could induce changes in increases in apoptosis-related proteins under hypoxic stress. Therefore, apoptosis marker expression in control and Sgsm3 KD cells under different oxygen conditions was observed via immunoblot analysis. Surprisingly, Sgsm3 KD remarkably inhibited the increases in cytochrome C, caspase-3 and caspase-9 induced by hypoxic stress (Fig 3B). These results suggest that Sgsm3 KD could block hypoxia-induced apoptosis.
Changes in cell viability (A) and apoptosis marker expression (B) in MSCs with Sgsm3 knockdown under normoxic and hypoxic conditions were measured using Ez-Cytox and immunoblot analysis, respectively. Band intensity was measured as the area density and analyzed in ImageJ and relative intensity levels indicate protein levels normalized to the β-actin levels. The data are representative of two independent experiments. Significant differences between groups were determined via ANOVA, with p values indicated as *p<0.05 and **p<0.01. N, normoxia; H, hypoxia; NC, negative control cells; KD, knockdown cells.
Effects of Sgsm3 KD on the expression levels of cardiomyogenic factors
We previously found alterations in cardiomyocyte differentiation-related proteins in MSCs exposed to hypoxia [10]. Here, we investigated whether Sgsm3 KD can cause increased expression of cardiomyogenic markers in MSCs under hypoxic stress using immunoblotting and immunofluorescent staining. Consequently, Sgsm3 KD significantly decreased the expression levels of cardiomyocyte differentiation-related proteins, except NKX2.5, under hypoxia (Fig 4A). Vascular endothelial growth factor (VEGF), which promotes cardiomyocyte differentiation, was investigated in Sgsm3 KD cells exposed to hypoxia, but there was no effect of Sgsm3 KD (Fig 4A). The differential expression of cardiomyogenic factors induced by Sgsm3 KD under normoxic and hypoxic conditions was validated in MSCs using immunofluorescent staining (Fig 4B). Additionally, the effects of Sgsm3 KD on the Wnt/β-catenin signaling pathway were investigated, and decreases in Wnt-3 and β-catenin/p-β-catenin expression and increases in p-glycogen synthase kinase 3 β (GSK3β) expression were found under hypoxic conditions (Fig 5). These results imply that Sgsm3 KD could inhibit differentiation into cardiomyocytes under hypoxic stress and affect the Wnt/β-catenin signaling pathway in MSCs.
Changes in cardiogenic marker expression upon Sgsm3 knockdown in MSCs were measured via immunoblot analysis (A) and immunocytochemical staining (B). Band intensity was measured as the area density and analyzed in ImageJ and relative intensity levels indicate protein levels normalized to the β-actin levels (A). The nuclei were stained with DAPI (B). Scale bar = 200 μm. The data are representative of two independent experiments. Significant differences between groups were determined via ANOVA, with p values indicated as *p<0.05 and **p<0.01. N, normoxia; H, hypoxia; NC, negative control cells; KD, knockdown cells.
Changes in Wnt/β-catenin pathway-related protein expression upon Sgsm3 knockdown in MSCs were measured via immunoblot analysis. Band intensity was measured as the area density and analyzed in ImageJ and relative intensity levels indicate protein levels normalized to the β-actin levels. The data are representative of two independent experiments. Significant differences between groups were determined via ANOVA, with p values indicated as *p<0.05 and **p<0.01. N, normoxia; H, hypoxia; NC, negative control cells; KD, knockdown cells.
Discussion
The SGSM family contains three members (SGSM1, SGSM2, and SGSM3) [32] and SGSMs are expressed in the central nervous system neurons and are involved in the RAP RAB family. This suggests that SGSMs play an essential part in neuronal signal transduction and vesicular transportation pathways [33]. Lan Z et al. first identified that SGSM3 interacts with Cx43 and induces its degradation, and these results suggest that SGSM3 may induce Cx43 turnover through the lysosomal pathway [34]. The Cx43 is affected by interactions between Cx43 and numerous proteins, which related to trafficking, channel construction, and degradation [35,36]. SGSM3 increases Cx43 turnover by accelerating the internalization of Cx43 from the plasma membrane [37]. On the other hand, several studies have shown that SGSM3 is associated with the risk of some cancers, including liver, breast, colorectal and bladder cancers [38–41].
We previously found that SGSM3 functions as a partner of Cx43 and inhibits Cx43 degradation in a rat MI model and cardiomyocytes [29,30]. Based on these previous data, we were curious whether SGSM3 also plays a role in cardiomyogenic differentiation in stem cells. We investigated the expression and interaction of Cx43 and SGSM3 in MSCs under low oxygen conditions, which could induce differentiation into cardiomyocytes and/or cells with comparable phenotypes in MSCs [10]. The results indicated that SGSM3 was decreased, whereas Cx43 was increased in rat MSCs under hypoxic stress. These results are consistent with the opposite expression pattern of Cx43/SGSM3 in a rat MI model and cardiomyocytes [29,30]. In addition, we found that Hif1a KD reduced Cx43 and ZO-1 expression but did not change SGSM3 expression, whereas Sgsm3 KD increased Hif1α and Cx43 expression and decreased ZO-1 expression under hypoxic conditions. These results indicate that SGSM3 is reduced by hypoxic stress in a HIF1α-independent manner and that SGSM3, HIF1α, and Cx43 are closely related; moreover, SGSM3 may induce Cx43 turnover in stem cells.
It was recently reported that connexins contribute to regulating cell growth and death. Wang D et al. investigated whether Cx43 affects MSC survival and improves therapeutic efficacy in a rat MI model [42]. The authors found that Cx43 overexpression improved cell survival and reduced infarct size in a rat MI model, indicating that Cx43 may act as a potential target for improving the therapeutic efficacy of MSCs in ischemic heart disease [42]. In addition, Cx43 expression in tongue muscle-derived stem cells was observed in the earlier stage of stem cell transplantation and contributed to less arrhythmogenicity, leading to improved survival in a mouse MI model [43]. In the present study, Sgsm3 KD ameliorated hypoxia-induced MSC death, which may be caused by Sgsm3 KD-induced increases in CX43.
MI and subsequent ischemic processes under low oxygen conditions result in extensive cardiomyocyte loss, and MSC-based therapies are gaining attention as a way to replace current techniques [44]. Although complete differentiation into functional cells has not yet been achieved, MSCs can differentiate into cardiac cell types [10,44]. In vivo studies have demonstrated that MSC-derived differentiated cells have electrophysiological functions similar to cells originating from cardiac tissue [45,46]. In addition, in vitro studies showed that MSCs have the ability to form functional gap junctions and cause voluntary rhythms [47,48]. Valiunas et al. suggested that gap junction proteins such as Cx40 and Cx43 may play a significant role in the physiology and/or pathology of cardiovascular tissues, including cardiac conduction properties and myoendothelial intercellular communication [48]. In fact, changes in Cx43 expression and distribution were shown in myocardium diseases such as hypertrophic cardiomyopathy, heart failure and ischemia [49]. In addition, Cx43 is important for maintaining late-passage MSCs during adipogenesis and regulates the osteogenic differentiation of bone marrow-derived MSCs [50,51]. These results imply that Cx43 may play a role in the cardiac differentiation of MSCs. However, to the best of our knowledge, there is no direct report about the effects of Cx43 on the cardiac differentiation of stem cells. Here, we found that Sgsm3 KD inhibits hypoxia-induced cardiac differentiation in MSCs, supporting the findings of increased Cx43 by Sgsm3 KD.
Together with the studies of the effects of Sgsm3 KD on cardiac differentiation, we investigated the influence of Sgsm3 KD on the Wnt/β-catenin pathway. Wnt/β-catenin signaling is critical in stem cell biology and is involved in cardiomyogenesis via canonical or noncanonical signaling [52,53]. β-catenin, which related to the canonical Wnt pathway, is a feature of Wnt signaling activation [54]. GSK3β is an intracellular inhibitor of the Wnt/β-catenin pathway and may block differentiation in stem cells [55]. In the current study, we found that SGSM3 KD may affect the Wnt/β-catenin pathway in a manner related to hypoxia-induced cardiogenic differentiation in MSCs. These results suggest that SGSM3 KD may attenuate cardiogenic differentiation in rat MSCs through a Wnt/β-catenin-dependent pathway.
We identified that SGSM3 interacts with Cx43 in rat MSCs under different oxygen conditions and that SGSM3 KD inhibits apoptosis and cardiomyocyte differentiation under hypoxic stress and affects the Wnt/β-catenin signaling pathway. SGSM3/Sgsm3 probably has an effect on MSC survival and has therapeutic potential in diseased hearts, but SGSM3 may worsen the development of MSC-based therapeutic approaches in regenerative medicine.
References
- 1. Via AG, Frizziero A, Oliva F (2012) Biological properties of mesenchymal Stem Cells from different sources. Muscles Ligaments Tendons J 2: 154–162. pmid:23738292
- 2. Guo X, Bai Y, Zhang L, Zhang B, Zagidullin N, et al. (2018) Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications. Stem Cell Res Ther 9: 44. pmid:29482607
- 3. Paino F, La Noce M, Giuliani A, De Rosa A, Mazzoni S, et al. (2017) Clin Sci (Lond) 131: 699–713.
- 4. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J (2019) Mesenchymal Stem Cells for Regenerative Medicine. Cells 8: 886.
- 5. Farzaneh M, Rahimi F, Alishahi M, Khoshnam SE (2019) Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes. Curr Stem Cell Res Ther 14: 9–13. pmid:30152289
- 6. Rosen MR, Myerburg RJ, Francis DP, Cole GD, Marban E (2014) Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J Am Coll Cardiol 64: 922–937. pmid:25169179
- 7. Ko IK, Kim BS (2008) Mesenchymal stem cells for treatment of myocardial infarction. Int J Stem Cells 1: 49–54. pmid:24855508
- 8. Simon MC, Keith B (2008) The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 9: 285–296. pmid:18285802
- 9. Krinner A, Zscharnack M, Bader A, Drasdo D, Galle J (2009) Impact of oxygen environment on mesenchymal stem cell expansion and chondrogenic differentiation. Cell Prolif 42: 471–484. pmid:19594581
- 10. Choi JW, Kim KE, Lee CY, Lee J, Seo HH, et al. (2016) Alterations in Cardiomyocyte Differentiation-Related Proteins in Rat Mesenchymal Stem Cells Exposed to Hypoxia. Cell Physiol Biochem 39: 1595–1607. pmid:27627433
- 11. Lennon DP, Edmison JM, Caplan AI (2001) Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 187: 345–355. pmid:11319758
- 12. Fink T, Abildtrup L, Fogd K, Abdallah BM, Kassem M, et al. (2004) Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia. Stem Cells 22: 1346–1355. pmid:15579652
- 13. Ren H, Cao Y, Zhao Q, Li J, Zhou C, et al. (2006) Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun 347: 12–21. pmid:16814746
- 14. Wang JA, Chen TL, Jiang J, Shi H, Gui C, et al. (2008) Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin 29: 74–82. pmid:18158868
- 15. Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M, et al. (2010) Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 299: C1562–1570. pmid:20861473
- 16. Yasui K, Kada K, Hojo M, Lee JK, Kamiya K, et al. (2000) Cell-to-cell interaction prevents cell death in cultured neonatal rat ventricular myocytes. Cardiovasc Res 48: 68–76. pmid:11033109
- 17. Lu G, Haider HK, Jiang S, Ashraf M (2009) Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 119: 2587–2596. pmid:19414636
- 18. Matsushita T, Oyamada M, Fujimoto K, Yasuda Y, Masuda S, et al. (1999) Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ Res 85: 1046–1055. pmid:10571536
- 19. Severs NJ, Bruce AF, Dupont E, Rothery S (2008) Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 80: 9–19. pmid:18519446
- 20. Smith JH, Green CR, Peters NS, Rothery S, Severs NJ (1991) Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol 139: 801–821. pmid:1656760
- 21. Rodriguez-Sinovas A, Sanchez JA, Gonzalez-Loyola A, Barba I, Morente M, et al. (2010) Effects of substitution of Cx43 by Cx32 on myocardial energy metabolism, tolerance to ischaemia and preconditioning protection. J Physiol 588: 1139–1151. pmid:20156849
- 22. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, et al. (2005) Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 97: 583–586. pmid:16100048
- 23. Ruiz-Meana M, Nunez E, Miro-Casas E, Martinez-Acedo P, Barba I, et al. (2014) Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. J Mol Cell Cardiol 68: 79–88. pmid:24434643
- 24. Laird DW, Puranam KL, Revel JP (1991) Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 273(Pt 1): 67–72.
- 25. Martins-Marques T, Anjo SI, Pereira P, Manadas B, Girao H (2015) Interacting Network of the Gap Junction (GJ) Protein Connexin43 (Cx43) is Modulated by Ischemia and Reperfusion in the Heart. Mol Cell Proteomics 14: 3040–3055. pmid:26316108
- 26. Giepmans BN (2004) Gap junctions and connexin-interacting proteins. Cardiovasc Res 62: 233–245. pmid:15094344
- 27. Chen VC, Kristensen AR, Foster LJ, Naus CC (2012) Association of connexin43 with E3 ubiquitin ligase TRIM21 reveals a mechanism for gap junction phosphodegron control. J Proteome Res 11: 6134–6146. pmid:23106098
- 28. Denuc A, Nunez E, Calvo E, Loureiro M, Miro-Casas E, et al. (2016) New protein-protein interactions of mitochondrial connexin 43 in mouse heart. J Cell Mol Med 20: 794–803. pmid:26915330
- 29. Lee CY, Choi JW, Shin S, Lee J, Seo HH, et al. (2017) Interaction of small G protein signaling modulator 3 with connexin 43 contributes to myocardial infarction in rat hearts. Biochem Biophys Res Commun 491: 429–435. pmid:28716730
- 30. Joo HC, Choi JW, Moon H, Lee CY, Yoo KJ, et al. (2018) Protective effects of kenpaullone on cardiomyocytes following H2O2-induced oxidative stress are attributed to inhibition of connexin 43 degradation by SGSM3. Biochem Biophys Res Commun 499: 368–373. pmid:29577900
- 31. Choi JW, Shin S, Lee CY, Lee J, Seo HH, et al. (2017) Rapid Induction of Osteogenic Markers in Mesenchymal Stem Cells by Adipose-Derived Stromal Vascular Fraction Cells. Cell Physiol Biochem 44: 53–65. pmid:29131029
- 32. Lindstrom S, Thompson DJ, Paterson AD, Li J, Gierach GL, et al. (2014) Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nat Commun 5: 5303. pmid:25342443
- 33. Yang H, Sasaki T, Minoshima S, Shimizu N (2007) Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway. Genomics 90: 249–260. pmid:17509819
- 34. Lan Z, Kurata WE, Martyn KD, Jin C, Lau AF (2005) Novel rab GAP-like protein, CIP85, interacts with connexin43 and induces its degradation. Biochemistry 44: 2385–2396. pmid:15709751
- 35. Sorgen PL, Trease AJ, Spagnol G, Delmar M, Nielsen MS (2018) Protein(-)Protein Interactions with Connexin 43: Regulation and Function. Int J Mol Sci 19.
- 36. Musil LS, Goodenough DA (1991) Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol 115: 1357–1374. pmid:1659577
- 37. Cochrane K, Su V, Lau AF (2013) The connexin43-interacting protein, CIP85, mediates the internalization of connexin43 from the plasma membrane. Cell Commun Adhes 20: 53–66. pmid:23586710
- 38. Wang C, Zhao H, Zhao X, Wan J, Wang D, et al. (2014) Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma. Tumour Biol 35: 295–301. pmid:23918301
- 39. Tan T, Zhang K, Chen W (2017) Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population. Breast Cancer 24: 369–374. pmid:27432265
- 40. Marques D, Ferreira-Costa LR, Ferreira-Costa LL, Correa RDS, Borges AMP, et al. (2017) Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features. World J Gastroenterol 23: 6854–6867. pmid:29085228
- 41. Hashemi M, Bahari G, Bizhani F, Danesh H, Sarhadi S, et al. (2018) Evaluation of 4-bp insertion/deletion polymorphism within the 3'UTR of SGSM3 in bladder cancer using mismatch PCR-RFLP method: A preliminary report. J Cell Biochem 119: 6566–6574. pmid:29693742
- 42. Wang D, Shen W, Zhang F, Chen M, Chen H, et al. (2010) Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. Cell Biol Int 34: 415–423. pmid:20067445
- 43. Shibuya M, Miura T, Fukagawa Y, Akashi S, Oda T, et al. (2010) Tongue muscle-derived stem cells express connexin 43 and improve cardiac remodeling and survival after myocardial infarction in mice. Circ J 74: 1219–1226. pmid:20410616
- 44. Szaraz P, Gratch YS, Iqbal F, Librach CL (2017) In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells. J Vis Exp.
- 45. Potapova I, Plotnikov A, Lu Z, Danilo P Jr., Valiunas V, et al. (2004) Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 94: 952–959. pmid:14988226
- 46. Plotnikov AN, Sosunov EA, Qu J, Shlapakova IN, Anyukhovsky EP, et al. (2004) Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation 109: 506–512. pmid:14734518
- 47. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, et al. (2004) Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22: 1282–1289. pmid:15448703
- 48. Valiunas V, Weingart R, Brink PR (2000) Formation of heterotypic gap junction channels by connexins 40 and 43. Circ Res 86: E42–49. pmid:10666425
- 49. Allen A (1992) The cardiotoxicity of chemotherapeutic drugs. Semin Oncol 19: 529–542. pmid:1411651
- 50. Shao Q, Esseltine JL, Huang T, Novielli-Kuntz N, Ching JE, et al. (2019) Connexin43 is Dispensable for Early Stage Human Mesenchymal Stem Cell Adipogenic Differentiation But is Protective against Cell Senescence. Biomolecules 9.
- 51. Lin FX, Zheng GZ, Chang B, Chen RC, Zhang QH, et al. (2018) Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways. Cell Physiol Biochem 47: 161–175. pmid:29763908
- 52. Fu WB, Wang WE, Zeng CY (2019) Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol Sin 40: 9–12. pmid:30002488
- 53. Mazzotta S, Neves C, Bonner RJ, Bernardo AS, Docherty K, et al. (2016) Distinctive Roles of Canonical and Noncanonical Wnt Signaling in Human Embryonic Cardiomyocyte Development. Stem Cell Reports 7: 764–776. pmid:27641648
- 54. Duchartre Y, Kim YM, Kahn M (2016) The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol 99: 141–149. pmid:26775730
- 55. Nakamura T, Sano M, Songyang Z, Schneider MD (2003) A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A 100: 5834–5839. pmid:12719544